Closed call · historical reference

H2020-JTI-IMI2-2015-05-two-stage · Patient perspective elicitation on benefits and risks of medicinal products, from development through the entire life cycle, to inform the decision-making process by regulators and Health Technology Assessment bodie

Specific Challenge:While there is an emerging consensus among stakeholders that patients’ values and perspectives are important to inform decision-making processes during the development of medicines as well as during the approval and post-approval phases, it is not clear when patient perspective e…